Kayne Anderson Rudnick Investment Management LLC Royalty Pharma PLC Transaction History

Kayne Anderson Rudnick Investment Management LLC

  • $43.7 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$37.53 - $44.22 $2,026 - $2,387
-54 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$37.46 - $42.44 $2,022 - $2,291
54 New
54 $2,000

Others Institutions Holding RPRX

# of Institutions
412
Shares Held
283M
Call Options Held
578K
Put Options Held
47.5K
View Full List

About Royalty Pharma plc

RPRX Quotes by TradingView
  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.3B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Kayne Anderson Rudnick Investment Management LLC Portfolio

Follow Kayne Anderson Rudnick Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kayne Anderson Rudnick Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kayne Anderson Rudnick Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email